SRX HEALTH SOLUTIONS INC (SRXH)
AMEXConsumer StaplesSoftware - ApplicationSnapshot 2026-09-04
$1.51-3.21%
Close 2026-09-04 · 1-day change
AMEXConsumer StaplesSoftware - ApplicationSnapshot 2026-09-04
Intact: The reason to own it still holds.
SRXH is growing revenue from $1.2M to $3.4M in 1.5 years. Operating losses fell from $17.4M to $1.8M in 3 quarters. The company aims to fix NYSE listing problems. These show progress in a tough market.
SRXH is still losing money and risks delisting from NYSE. Revenue is small and growth may not last. Legal and regulatory problems could hurt the company more.
The market expects a 17.5% growth over 3 years but forecasts show -15.3%. The stock price reflects high risk and uncertain recovery.
Breaks if: Revenue falls below $3.4M next 4 quarters
Breaks if: Operating loss worsens beyond -$1.8M next 2 quarters
Fails to regain NYSE compliance by 2026-Q4
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround play in the Consumer Staples sector. The current thesis state indicates volatility, with recent performance being weak and management facing high risks.
The market appears to have priced in a low level of fragility, suggesting that there are no immediate concerns about stability. However, the premium valuation compared to peers indicates that expectations for recovery may be somewhat optimistic.
Fundamentals are likely to remain under pressure in the near term due to a high probability of an earnings miss. Recent financial performance has been weak, and the company has experienced a significant drop in momentum.
The long-term thesis hinges on key factors such as management's ability to execute on capital allocation and M&A strategies, as well as external conditions like inflation trends and the performance of sector leaders. Any guidance cuts could negatively impact sentiment.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
In the next 1 to 3 years, SRXH's outlook will depend on its execution and market conditions. Not investment advice.